AISLING CAPITAL
Aisling Capital believes the next decade will be marked by a revolution in healthcare driven by new therapeutics generated by biotechnology. The completion of the human genome has given scientists new insights into the causes of human disease. These insights, combined with the past 20 years of developments in the biotechnology industry, are leading to rapid expansion of novel approaches toward the diagnosis, prevention, and treatment of life-threatening illnesses. These advances have led to an ever-increasing demand for capital to complete the development and commercialization of new therapeutics. Our goal is to support the leading global healthcare companies that are building on these technical and medical breakthroughs to commercialize new healthcare products.
AISLING CAPITAL
Industry:
Biotechnology Health Care Venture Capital
Founded:
2000-01-01
Status:
Active
Contact:
(212) 651-6379
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF WordPress Google Maps Amazon SSL By Default IPv6 ReCAPTCHA Nginx
Similar Organizations
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
PolyCore Therapeutics
PolyCore Therapeutics’ team of life sciences scientists is dedicated to developing breakthrough treatments for CNS Diseases.
RegDesk
Bringing Speed and Certainty to Life Sciences
Rx Green Technologies
Rx Green Technologies delivers and supports research-backed products to commercial cannabis cultivators.
Stabiliz Orthopaedics
Stabiliz Orthopaedics develops novel enhancements for orthopedic medical devices using FDA-approved technologies.
Tivorsan Pharmaceuticals
Tivorsan Pharmaceuticals is a protein therapeutics company that focuses on treating neuromuscular disorders.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Tridiuum
Tridiuum is a digital health company that is advancing the treatment of behavioral health conditions.
Current Employees Featured
Steven A. Elms Managing Partner @ Aisling Capital
Managing Partner
Stacey Seltzer​ Partner @ Aisling Capital
Partner
2014-09-01
Dennis Purcell Founder & Senior Advisor @ Aisling Capital
Founder & Senior Advisor
1998-01-01
Scott Braunstein Operating Partner @ Aisling Capital
Operating Partner
2015-08-10
Aftab Kherani Operating Partner @ Aisling Capital
Operating Partner
2020-01-01
Andrew Schiff Managing Partner @ Aisling Capital
Managing Partner
1999-09-01
Jan Hoerrner Director of Investor Relations & Marketing @ Aisling Capital
Director of Investor Relations & Marketing
2000-10-01
Eric Aguiar Partner @ Aisling Capital
Partner
2016-01-06
Josh Bilenker Partner @ Aisling Capital
Partner
2012-01-01
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2024-05-02 | BridgeBio Oncology Therapeutics | Aisling Capital investment in Venture Round - BridgeBio Oncology Therapeutics | 200 M USD |
| 2024-01-22 | CalciMedica | Aisling Capital investment in Post-IPO Equity - CalciMedica | 55 M USD |
| 2023-12-12 | Bicara Therapeutics | Aisling Capital investment in Series C - Bicara Therapeutics | 165 M USD |
| 2023-08-16 | COMPASS Pathways | Aisling Capital investment in Post-IPO Equity - COMPASS Pathways | 125 M USD |
| 2023-02-07 | Garuda Therapeutics | Aisling Capital investment in Series B - Garuda Therapeutics | 62 M USD |
| 2022-09-12 | Forge Biologics | Aisling Capital investment in Series C - Forge Biologics | 90 M USD |
| 2022-06-14 | Dren Bio | Aisling Capital investment in Series B - Dren Bio | 65 M USD |
| 2021-11-03 | Antios Therapeutics | Aisling Capital investment in Series B - Antios Therapeutics | 75 M USD |
| 2021-09-23 | Garuda Therapeutics | Aisling Capital investment in Series A - Garuda Therapeutics | 72 M USD |
| 2021-07-15 | Wugen | Aisling Capital investment in Series B - Wugen | 172 M USD |
More informations about "Aisling Capital"
About - Aisling Capital
Aisling Capital makes investment decisions driven by fundamental assessment of scientific, regulatory, financial and commercial risks. Given our investment team’s broad skillset, we …See details»
Team - Aisling Capital
Dr. Aguiar joined Aisling in 2016 and serves as a Partner. Prior to Aisling, Dr. Aguiar was a partner at Thomas, McNerney and Partners, a $600 million healthcare-focused venture capital …See details»
Aisling Capital - Crunchbase Investor Profile
Aisling Capital believes the next decade will be marked by a revolution in healthcare driven by new therapeutics generated by biotechnology. The completion of the human genome has given scientists new insights into the …See details»
Aisling Capital - LinkedIn
Aisling Capital believes the next decade will be marked by a revolution in healthcare driven by new therapeutics generated by biotechnology. The completion of the human genome has …See details»
Aisling Capital - Investments, Portfolio & Company Exits
Aisling Capital 's most notable exits include Poseida Therapeutics, Biomea Fusion, and Elevation Oncology. Which industries has this organization had the most exits in? Show . Poseida …See details»
Aisling Capital – Divestopedia
Nov 9, 2023 Aisling Capital is a leading investment firm that advises investment funds that invest in products, technologies, and global businesses that advance health. Aisling Capital is led by a group of investment …See details»
Aisling Capital - Investor Profile, Portfolio & Team - Tracxn
Aug 17, 2021 UK-based COMPASS Pathways secures €261.8M to advance mental health solutionsSilicon Canals • Aug 17, 2023 • COMPASS Pathways, TCG Crossover, Aisling …See details»
Aisling Capital - CB Insights
Feb 11, 2017 Aisling Capital, a private equity firm, believes the next decade will be marked by a revolution in healthcare driven by new therapeutics generated by biotechnology. The …See details»
Aisling Capital - Private Equity Investments & Executives
See Aisling Capital's 129 investments, 10 executives, and complete investor profile. Founded in 2000, Aisling Capital is an investment firm that invests in companies developing and …See details»
Aisling Capital investment portfolio - PitchBook
Aisling Capital General Information Company Description. Founded in 2000, Aisling Capital is a venture capital firm based in New York, New York. The firm seeks to invest in healthcare & life science sectors based in the Canada …See details»
Aisling Capital - Private Equity List
AISLING CAPITAL IS A LEADING INVESTMENT FIRM THAT INVESTS IN COMPANIES DEVELOPING AND COMMERCIALIZING IMPORTANT AND INNOVATIVE HEALTHCARE …See details»
Portfolio - Aisling Capital
Aisling Capital invests in products, technologies and businesses that advance health. In addition to investing in companies developing pharmaceutical, biotechnology and medical products, …See details»
Aisling Capital Company Profile - Office Locations, Competitors
Aisling Capital is a leading investment firm that invests in products, technologies, and global businesses that advance health.Since 2000, aisling capital has raised over $1.8 billion in …See details»
Aisling Capital Portfolio Companies - Crunchbase
Mar 12, 2006 Aisling Capital believes the next decade will be marked by a revolution in healthcare driven by new therapeutics generated by. This list of organizations invested in by …See details»
Aisling Capital - Leading investment firm that invests in companies ...
Aisling Capital takes an active approach to investing, working closely with portfolio companies to help them become value-building enterprises with multiple opportunities for exit. Our …See details»
Aisling Capital Mergers and Acquisitions Summary | Mergr
In the last 3 years, Aisling Capital has acquired 1 company.It has also invested in 1 other.. Aisling Capital’s most common sectors for investment arelife science (75%) and medical products …See details»
AISLING CAPITAL LLC Top 13F Holdings - WhaleWisdom.com
Sep 30, 2024 AISLING CAPITAL LLC 0 followers · Follow Like 5 events NEW YORK NY Investment Advisor. 13F Summary. Create Email Alert Aisling Capital is based out of New …See details»
Maria Georgiadis - Aisling Capital - LinkedIn
Resourceful and detail-oriented with strong analytical, organization, and communication… · Experience: Aisling Capital · Education: Hunter College · Location: New York City Metropolitan …See details»
Aisling Capital - Contacts, Employees, Board Members
Aisling Capital has 9 current employee profiles, including Managing Partner Steven A. Elms. Contacts. Edit Contacts Section. Job Department. Protected Content. Founder and Senior …See details»
AIP Capital Expands Leadership Team - Newswire
18 hours ago AIP Capital (AIP) is a global alternative investment manager focused on opportunities in asset-based finance with approximately $3 billion of assets under …See details»